Mankind Pharma shares end 8-session losing streak on acquisition of BSV
The pharma company has acquired 100% stake in Bharat Serums and Vaccines Ltd (BSV), which will be funded through a combination of internal accruals and external debt.
The pharma company has acquired 100% stake in Bharat Serums and Vaccines Ltd (BSV), which will be funded through a combination of internal accruals and external debt.
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
The move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian women's health and fertility drug market.
The company’s effort to find a new method to treat Covid-19 patients comes at a time when India is in the midst of a third wave of infection.